Vectus Biosystems Ltd has released a press release.
Reinstatement to Quotation
Filed with ASX ·
6ix hasn’t read this filing yet.
Vectus Biosystems Limited on 6ix
Story so far
Earlier from Vectus Biosystems
- VB4-P5 Renal Compound Transaction
- Suspension from Quotation
- Trading Halt
- Pause in Trading
- Preliminary Final Report
Later from Vectus Biosystems
- Response to ASX Query Letter
- Quarterly Activities & Appendix 4C Cash Flow Reports
- Half Year Report & Appendix 4D
- VB4-P5 Renal Compound Transaction Settled
- Appointment of Dr Tara Speranza as CEO & CTO
Follow Vectus Biosystems into a list and get an email when it puts out news.
Follow Vectus Biosystems